• 1. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 4. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Ethyl 5-(4-biphenyl)-5-oxovalerate (CAS No. 138247-17-3): A Comprehensive Overview

Ethyl 5-(4-biphenyl)-5-oxovalerate (CAS No. 138247-17-3) is a specialized organic compound that has garnered significant attention in the field of chemical and pharmaceutical research. This compound, characterized by its unique structural and functional properties, is being explored for various applications, particularly in the development of novel therapeutic agents and advanced materials. The molecular structure of Ethyl 5-(4-biphenyl)-5-oxovalerate consists of a valerate ester moiety linked to a biphenyl ring, which endows it with distinct chemical reactivity and potential biological activity.

The biphenyl core in Ethyl 5-(4-biphenyl)-5-oxovalerate is a key feature that contributes to its versatility. Biphenyl derivatives are well-known for their broad spectrum of biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. The presence of the valerate ester group further enhances the compound's potential by facilitating interactions with biological targets. This combination of structural elements makes Ethyl 5-(4-biphenyl)-5-oxovalerate an attractive candidate for further investigation in drug discovery and material science.

In recent years, there has been a growing interest in the development of novel compounds with enhanced pharmacological properties. Ethyl 5-(4-biphenyl)-5-oxovalerate has been studied for its potential role in modulating various biological pathways. Research indicates that this compound may exhibit inhibitory effects on certain enzymes and receptors, which could be beneficial in the treatment of neurological disorders and chronic inflammatory conditions. The biphenyl moiety, in particular, has been shown to interact with specific binding sites, suggesting its potential as a lead compound for the development of new therapeutic agents.

The synthesis of Ethyl 5-(4-biphenyl)-5-oxovalerate involves a series of carefully controlled chemical reactions that highlight the expertise required in organic synthesis. The process typically begins with the preparation of the biphenyl derivative, followed by the introduction of the valerate ester group. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions, have been employed to ensure high yields and purity. These methods underscore the importance of precision and innovation in modern chemical research.

One of the most compelling aspects of Ethyl 5-(4-biphenyl)-5-oxovalerate is its potential application in medicinal chemistry. The compound's unique structure allows it to mimic natural bioactive molecules, thereby serving as a scaffold for drug design. Researchers have leveraged computational modeling and high-throughput screening to identify derivatives of Ethyl 5-(4-biphenyl)-5-oxovalerate with enhanced pharmacological properties. These efforts have led to promising candidates for further clinical development.

The role of computational chemistry in studying Ethyl 5-(4-biphenyl)-5-oxovalerate cannot be overstated. Molecular dynamics simulations and quantum mechanical calculations have provided valuable insights into the compound's interactions with biological targets. These studies have helped elucidate the mechanisms by which Ethyl 5-(4-biphenyl)-5-oxovalerate exerts its effects, paving the way for more targeted drug design strategies.

In addition to its pharmaceutical applications, Ethyl 5-(4-biphenyl)-5-oxovalerate has shown promise in materials science. Its unique structural features make it suitable for use as a building block in the development of advanced polymers and coatings. These materials could find applications in various industries, including electronics and aerospace, where high-performance properties are essential.

The future prospects for Ethyl 5-(4-biphenyl)-5-oxovalerate are vast and exciting. Ongoing research is focused on optimizing its synthesis, exploring new derivatives, and evaluating its potential in preclinical studies. As our understanding of biological systems continues to evolve, compounds like Ethyl 5-(4-biphenyl)-5-oxovalerate are poised to play a crucial role in addressing some of the most pressing challenges in medicine and materials science.

• 677326-79-3(ethyl 3-(3-biphenyl)-3-oxopropanoate)
• 89326-67-0(Benzenebutanoic acid, 4-(1-oxopropyl)-, ethyl ester)
• 57477-98-2(Ethyl 3-(4-biphenyl)-3-oxopropanoate)
• 898751-46-7( )
• 6308-43-6(Benzenepentanoic acid,4-(3-carboxy-1-oxopropyl)-, 1-ethyl ester)
• 6942-61-6(Ethyl 4-(4-methylphenyl)-4-oxobutyrate)
• 898751-69-4( )
• 89326-66-9(Benzenepropanoic acid, 4-(1-oxobutyl)-, ethyl ester)
• 147862-41-7(Ethyl 7-(4-biphenyl)-7-oxoheptanoate)
• 1230-54-2(Ethyl 4-(4-biphenyl)-4-oxobutyrate)